Twist Bioscience (TWST) PT Lowered to $40 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts TWST Hot Sheet
Price: $140.30 --0%
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Barclays analyst Luke Sergott lowered the price target on Twist Bioscience (NASDAQ: TWST) to $40.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Why the Next Edge in Antibody Discovery May Be What Labs Remember
- Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,000 at Axis Capital Limited
- Ventive Hospitality (VENTIVE:IN) PT Lowered to INR638 at Axis Capital Limited
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
